However, the between-group difference did not reach statistical significance ( p = 0.373).
← all excerpts
Effect of sitagliptin vs. placebo on bone mineralization in women with type 2 diabetes: the SLowDOWN (SitagLiptin in Diabetes for Osteoporosis in WomeN) randomized clinical trial.
1
0.3730
0.3730